Diamanti-Kandarakis E - Search Results

1

Implications and Future Perspectives of AGEs in PCOS Pathophysiology.

Merhi Z, Kandaraki EA, Diamanti-Kandarakis E. Merhi Z, et al. Trends Endocrinol Metab. 2019 Mar;30(3):150-162. doi: 10.1016/j.tem.2019.01.005. Epub 2019 Feb 1. Trends Endocrinol Metab. 2019. PMID: 30712978 Review.

2

Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).

Diamanti-Kandarakis E, Katsikis I, Piperi C, Kandaraki E, Piouka A, Papavassiliou AG, Panidis D. Diamanti-Kandarakis E, et al. Clin Endocrinol (Oxf). 2008 Oct;69(4):634-41. doi: 10.1111/j.1365-2265.2008.03247.x. Epub 2008 Mar 19. Clin Endocrinol (Oxf). 2008. PMID: 18363886

3

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.

Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN. Diamanti-Kandarakis E, et al. Eur J Endocrinol. 2010 Feb;162(2):193-212. doi: 10.1530/EJE-09-0733. Epub 2009 Oct 19. Eur J Endocrinol. 2010. PMID: 19841045 Review.

4

Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats.

Chatzigeorgiou A, Kandaraki E, Piperi C, Livadas S, Papavassiliou AG, Koutsilieris M, Papalois A, Diamanti-Kandarakis E. Chatzigeorgiou A, et al. J Endocrinol. 2013 Aug 29;218(3):331-7. doi: 10.1530/JOE-13-0175. Print 2013 Sep. J Endocrinol. 2013. PMID: 23823020

5

Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome?

Pertynska-Marczewska M, Diamanti-Kandarakis E, Zhang J, Merhi Z. Pertynska-Marczewska M, et al. Metabolism. 2015 Nov;64(11):1564-73. doi: 10.1016/j.metabol.2015.08.010. Epub 2015 Aug 20. Metabolism. 2015. PMID: 26386695 Review.

6

The Role of Androgen Excess on Insulin Sensitivity in Women.

Diamanti-Kandarakis E, Papalou O, Kandaraki EA. Diamanti-Kandarakis E, et al. Front Horm Res. 2019;53:50-64. doi: 10.1159/000494902. Epub 2019 Sep 9. Front Horm Res. 2019. PMID: 31499502 Review.

7

Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART).

Facchinetti F, Espinola MSB, Dewailly D, Ozay AC, Prapas N, Vazquez-Levin M, Wdowiak A, Unfer V; Expert Group on Inositols in Preclinical and Clinical Research. Facchinetti F, et al. Trends Endocrinol Metab. 2020 Aug;31(8):570-579. doi: 10.1016/j.tem.2020.04.003. Epub 2020 May 15. Trends Endocrinol Metab. 2020. PMID: 32418772 Review.

8

Tailoring treatment for PCOS phenotypes.

Papadakis G, Kandaraki EA, Garidou A, Koutsaki M, Papalou O, Diamanti-Kandarakis E, Peppa M. Papadakis G, et al. Among authors: diamanti kandarakis e. Expert Rev Endocrinol Metab. 2021 Jan;16(1):9-18. doi: 10.1080/17446651.2021.1865152. Epub 2020 Dec 31. Expert Rev Endocrinol Metab. 2021. PMID: 33382003

9

Accumulation of dietary glycotoxins in the reproductive system of normal female rats.

Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, Kandaraki E, Levidou G, Papalois A, Patsouris E, Papavassiliou AG. Diamanti-Kandarakis E, et al. J Mol Med (Berl). 2007 Dec;85(12):1413-20. doi: 10.1007/s00109-007-0246-6. Epub 2007 Aug 11. J Mol Med (Berl). 2007. PMID: 17694292

10

Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS).

Diamanti-Kandarakis E, Argyrakopoulou G, Economou F, Kandaraki E, Koutsilieris M. Diamanti-Kandarakis E, et al. J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):242-6. doi: 10.1016/j.jsbmb.2008.03.014. Epub 2008 Mar 12. J Steroid Biochem Mol Biol. 2008. PMID: 18440223 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters